74 related articles for article (PubMed ID: 38628547)
1. Design of a targeted dual drug delivery system for boosting the efficacy of photoimmunotherapy against melanoma proliferation and metastasis.
Chen Y; Xu S; Ren S; Zhang J; Xu J; Song Y; Peng J; Zhang S; Du Q; Chen Y
J Adv Res; 2024 May; ():. PubMed ID: 38768811
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.
Fujiwara Y; Kato S; Nesline MK; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Treat Rev; 2022 Nov; 110():102461. PubMed ID: 36058143
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.
Chen X; Pan X; Zhang W; Guo H; Cheng S; He Q; Yang B; Ding L
Acta Pharm Sin B; 2020 May; 10(5):723-733. PubMed ID: 32528824
[TBL] [Abstract][Full Text] [Related]
4. A lipid/PLGA nanocomplex to reshape tumor immune microenvironment for colon cancer therapy.
Zhang N; Sun Q; Li J; Li J; Tang L; Zhao Q; Pu Y; Liang G; He B; Gao W; Chen J
Regen Biomater; 2024; 11():rbae036. PubMed ID: 38628547
[TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Doxorubicin and Anti-PD-L1 Peptide in Lipid/PLGA Nanocomplexes for the Chemo-Immunotherapy of Cancer.
Zhang N; Li J; Gao W; Zhu W; Yan J; He Z; Li L; Wu F; Pu Y; He B
Mol Pharm; 2022 Sep; 19(9):3439-3449. PubMed ID: 35994700
[TBL] [Abstract][Full Text] [Related]
6. Multi-shell structured upconversion nanocarriers that combine IDO inhibitor-induced immunotherapy with NIR-triggered photodynamic therapy for deep tumors.
Choi J; Kim SY
Biomater Sci; 2023 Jun; 11(13):4684-4699. PubMed ID: 37219321
[TBL] [Abstract][Full Text] [Related]
7. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
[TBL] [Abstract][Full Text] [Related]
8. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
[TBL] [Abstract][Full Text] [Related]
9. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-activatable nanomedicine meets cancer theranostics.
Li H; Feng Y; Luo Q; Li Z; Li X; Gan H; Gu Z; Gong Q; Luo K
Theranostics; 2023; 13(15):5386-5417. PubMed ID: 37908735
[TBL] [Abstract][Full Text] [Related]
11. A construct of adipose-derived mesenchymal stem cells-laden collagen scaffold for fertility restoration by inhibiting fibrosis in a rat model of endometrial injury.
Dai Y; Xin L; Hu S; Xu S; Huang D; Jin X; Chen J; Chan RWS; Ng EHY; Yeung WSB; Ma L; Zhang S
Regen Biomater; 2023; 10():rbad080. PubMed ID: 37808957
[TBL] [Abstract][Full Text] [Related]
12. Albumin-based nanosystem for dual-modality imaging-guided chem-phototherapy against immune-cold triple-negative breast cancer.
Peng C; Zeng X; Cai J; Huang H; Yang F; Jin S; Guan X; Wang Z
Regen Biomater; 2023; 10():rbad073. PubMed ID: 37799708
[TBL] [Abstract][Full Text] [Related]
13. IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy.
Park J; Nah Y; Kim WJ
J Control Release; 2023 Nov; 363():496-506. PubMed ID: 37788761
[TBL] [Abstract][Full Text] [Related]
14. Nano-enabled colorectal cancer therapy.
Pan Q; Fan X; Xie L; Wu D; Liu R; Gao W; Luo K; He B; Pu Y
J Control Release; 2023 Oct; 362():548-564. PubMed ID: 37683732
[TBL] [Abstract][Full Text] [Related]
15. Nature-inspired nanocarriers for improving drug therapy of atherosclerosis.
Ji W; Zhang Y; Deng Y; Li C; Kankala RK; Chen A
Regen Biomater; 2023; 10():rbad069. PubMed ID: 37641591
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
